The IPO market slowed down in August but it looks like first-time offerings will regain their momentum in September, still on track for 2021 to be the most active year since the dot-com boom year of 2000, according to the IPO-tracking firm Renaissance Capital.
The biopharma industry has been a big driver in terms of the number of IPOs in the US this year with 84 offerings as of mid-August when RenovoRx, Inc....
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Scrip for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?